Cargando…
Refractory Bullous Systemic Lupus Erythematosus Successfully Treated with Rituximab: A Case Report and Literature Review
Bullous systemic lupus erythematosus (BSLE) is a rare blistering skin manifestation of systemic lupus erythematosus (SLE). Dapsone is reported to be helpful in mild-to-moderate BSLE cases; however, its use may be limited or prohibited due to particular complications such as drug hypersensitivity, do...
Autores principales: | Ratanapokasatit, Yanisa, Seree-Aphinan, Chutima, Chanprapaph, Kumutnart |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082637/ https://www.ncbi.nlm.nih.gov/pubmed/37038449 http://dx.doi.org/10.2147/CCID.S403866 |
Ejemplares similares
-
Optimal time for COVID-19 vaccination in rituximab-treated dermatologic patients
por: Seree-aphinan, Chutima, et al.
Publicado: (2023) -
Coexistence of Discoid Lupus Erythematosus and Paraneoplastic Pemphigus: A Case Report and Literature Review
por: Saowaluksakul, Wasin, et al.
Publicado: (2022) -
Inactivated COVID-19 Vaccine Induces a Low Humoral Immune Response in a Subset of Dermatological Patients Receiving Immunosuppressants
por: Seree-aphinan, Chutima, et al.
Publicado: (2021) -
Vesiculobullous diseases in relation to lupus erythematosus
por: Rutnin, Suthinee, et al.
Publicado: (2019) -
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies
por: Petricca, Luca, et al.
Publicado: (2020)